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INTRODUCTION
Fatty acids (FAs) are components of most cellular lipids, including glycerolipids, sphingolipids, and cholesterol esters, and their metabolism is closely related to disorders such as metabolic syndrome and lifestyle-related diseases. FAs comprise carbon chains of highly diverse chain-lengths and number of double bonds, with FAs of chain length of > 20 termed very long-chain FAs (VLCFAs). In mammals, most saturated and monounsaturated VLCFAs are components of sphingolipids and are important for skin barrier formation, neural functions, and functional maintenance of the liver (1-3). Mammalian polyunsaturated VLCFAs are used in the generation of glycerolipids and precursors of lipid mediators, which have many physiological roles in cellular processes such as resolution of inflammation and retinal functions (3) (4) (5) . In yeast, the major VLCFA is a saturated FA with a carbon chain length of 26 (C26:0) that is found in sphingolipids but also in glycosylphosphatidylinositol (GPI) anchors (6, 7) . Yeast VLCFAs function in the maintenance of nuclear envelope integrity and in the secretory pathway (8) (9) (10) (11) . Yeast mutants deficient in VLCFA synthesis are inviable (12) , indicating that functions of VLCFAs cannot not be substituted for by long-chain FAs.
VLCFAs are synthesized through the elongation of long-chain FAs or shorter VLCFAs by endoplasmic reticulum (ER) membrane-embedded enzymes (13) . The elongation proceeds by a four step cycle: 1) condensation of malonyl-CoA with acyl-CoA to produce 3-ketoacyl-CoA, 2) reduction of the 3-ketoacyl-CoA to 3-hydroxyacyl-CoA, 3) dehydration of 3-hydroxyacyl-CoA to 2,3-trans enoyl-CoA, and 4) reduction of 2,3-trans enoyl-CoA to an acyl-CoA that has a chain length of two more carbons than the precursor acyl-CoA.
The first condensation reaction is the rate-limiting step, and in yeast is catalyzed by two redundant elongases, Fen1 and Sur4 (14) . Fen1 and Sur4 determine the length of the VLCFA products. Sur4 produces C26 VLCFA, whereas Fen1 is involved in the production of C24 or shorter VLCFAs (14, 15) . Yeast cells carrying deletions for both FEN1 and SUR4 are inviable, yet fen1Δ and sur4Δ single mutants are viable (12) .
In yeast, the sphingolipid backbone ceramide is composed of a long-chain base and an amide bond-linked VLCFA (16, 17) . The addition of a polar head group to ceramide results in a complex sphingolipid. There are three classes of complex sphingolipids in yeast, inositol phosphorylceramides (IPCs), mannosylinositol phosphorylceramides (MIPCs), and mannosyldiinositol phosphorylceramides (M(IP) 2 Cs) (16) . IPCs contain phosphoinositol as a polar group and are synthesized by Aur1 (18) . Mannose is added to an IPC by the redundant enzymes Csg1 and Csh1, generating a MIPC (19) . An additional phosphoinositol is transferred to the MIPC by Ipt1, producing M(IP) 2 C (20) . Yeast mutant cells lacking all complex sphingolipids (aur1Δ) are inviable, while those lacking M(IP) 2 Cs (ipt1Δ) and those lacking both MIPCs and M(IP) 2 Cs but containing IPCs (csg1Δ csh1Δ) exhibit normal vegetative growth (16, (18) (19) (20) .
Involvement of VLCFAs in the yeast secretory pathway has been reported. For example, cells harboring deletions in both the SNC1 and SNC2 genes, which encode soluble NSF attachment protein receptors (SNAREs) found on secretory vesicles, exhibit a temperature-sensitive growth phenotype and a reduction in invertase secretion (11) . These phenotypes were suppressed by a loss of function mutation in SUR4 or FEN1, implying that VLCFAs are potentially involved in the secretory pathway (11) . In addition, in sur4Δ cells, the plasma membrane-localized H + -ATPase Pma1 is mis-targeted to the vacuole (8) , and an interruption in the transcription of PHS1, which encodes the 3-hydroxyacyl-CoA dehydratase that catalyzes the third step of the VLCFA elongation cycle, results in impaired accumulation of mature Gas1, a GPI-anchored protein localized in the plasma-membrane (9) . Thus, involvement of VLCFAs in secretory pathways is now recognized.
However, no report has clearly demonstrated involvement of VLCFAs in the vesicular trafficking pathway that functions in transport toward the vacuole. This is probably due to difficulties in assessing their importance under VLCFA-null, lethal conditions, in which any indirect effects could not be excluded. Thus, investigation of VLCFA's function under mild conditions is required for more understanding.
In the study presented here, we carried out a genetic screen to identify genes involved in VLCFA functions. We identified the Rab GTPase VPS21 as a multicopy suppressor of a yeast mutant with limited VLCFA synthesis. Analyses of a sur4Δ vps21Δ double mutant suggested that VLCFAs are involved in Vps21-related vesicular transport processes. Furthermore, the gene SUR4 exhibited interactions with genes encoding the CORVET subunits that function in tethering of vesicles to the late endosome/multivesicular body (MVB). Considering that any yeast mutant unable to synthesize VLCFA is nonviable, VLCFAs must be important for several essential cellular processes, such as general vesicular transport. However, transport defects at the endosome appeared even under the mild, VLCFA-limited conditions used here, suggesting that the requirement for VLCFAs is especially high in the endosomal trafficking pathways.
MATERIALS AND METHODS

Yeast strains and media
The Saccharomyces cerevisiae strains used in this study are listed in Table 1 . Cells were grown in YPD medium (1% yeast extract, 2% peptone, and 2% D-glucose) or in synthetic dextrose (SD) medium (0.67% yeast nitrogen base without amino acids and 2% D-glucose) supplemented with 0.5% casamino acid and appropriate supplements. Single deletion mutants, except MRY106 (vps19Δ::LEU2) was purchased from Open Biosystems (Huntsville, AL). Gene disruption was performed by replacing the entirety or part of the coding region with a marker gene.
Screening of multicopy suppressors
MRY9 (P tetO7 -PHS1 sur4Δ) cells were transfected with a yeast genomic library, in which genomic DNAs were cloned into the yeast expression vector pRS426 (2 µ, URA3 marker) (21) . A pool of approximately 30,000 Ura + clones were plated on YPD plates and incubated for 4 days at 39 ˚C. Plasmids were prepared from the 16 clones obtained and were re-introduced into MRY9. Of the 16 plasmids, 2 reproducibly restored growth of MRY9 at 39 ˚C. Sequences of the DNA fragments inserted into the two plasmids were determined using a 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA). Sequencing revealed that one plasmid contained the SUR4 gene, and the other (pMR22) contained the VPS21 and YVC1 genes and the asparagine tRNA gene tN(GUU)O2. The pMR31 (VPS21) and pMR30 (YVC1 and tN(GUU)O2) plasmids were created by subcloning the respective genes from the pMR22 plasmid into the pRS426 vector.
Plasmid construction
The pOK489 (mRFP-CPS1) and pOK529 (STE2-mRFP) plasmids were constructed as follows. The respectively. The mRFP sequence was amplified by PCR from pOK107 so that BamHI and XhoI sites were generated at the 5' and 3' ends, respectively. These fragments were cloned together into the SacI-XhoI site of the p416TEF plasmid (23) , creating the pOK529 plasmid.
The pMR8 (FEN1) and pMR10 (SUR4) plasmids were constructed as follows. The promoter, coding region, and 3'-UTR of these genes were amplified by PCR with creation of BamHI site at the 5' end. The amplified fragments of FEN1 and SUR4 were first cloned into the pGEM-T Easy vector (Promega, Madison, WI), then BamHI-NotI fragments of the resulting plasmids were transferred to the yeast expression vector pRS316 (CEN, URA3 marker) (24) , producing the pMR8 and pMR10 plasmids.
FA elongation assays
In vitro FA elongation assays were performed essentially as described previously (25) . 
Immunoblotting
Total cell lysates were prepared by the alkaline/trichloroacetic acid method as described previously (22) . Pep4 signal was enhanced using Can Get Signal Immunoreaction Enhancer Solution (TOYOBO, Osaka, Japan).
Pulse-chase experiment
Cells were grown at 30 ˚C in SD medium containing appropriate supplements but lacking methionine and cysteine. Cells (2.0 A 600 units) were pulse-labeled with 100 µCi [ Bio-Sciences), and detected using a bioimaging analyzer BAS-2500 (Fuji Photo Film, Tokyo, Japan).
Microscopy
Cells were cultured to log phase in SD medium supplemented with 0.5% casamino acid and appropriate supplements, and observed under a fluorescence microscope (Axioimager M2, Carl Zeiss, Oberkochen,
Germany).
RESULTS
Yeast cells' requirement of VLCFAs for growth is significant at elevated temperature
To begin to understand the functions of VLCFA in yeast, we first examined their roles in growth using a mutant with reduced VLCFA synthesis. Complete abrogation of VLCFA synthesis, such as that resulting from a double deletion of the redundant elongases FEN1 and SUR4, is lethal (12), so we first examined the growth of fen1Δ and sur4Δ single mutant cells at high temperature. Both mutants exhibited normal growth at 30 ˚C, yet at 39 ˚C the growth of the sur4Δ cells was retarded compared to the growth of wild type cells (Fig. 1A ).
This phenotype was enhanced by decreasing the levels of the 3-hydroxyacyl-CoA dehydratase Phs1, which is involved in the third step of the VLCFA elongation cycle, using genetic manipulation. Replacement of the PHS1 promoter with the doxycycline-dependent tetO 7 promoter (P tetO7 ) reduces the Phs1 levels to approximately 1/20 normal even in the absence of doxycycline treatment (26) . P tetO7 -PHS1 sur4Δ cells could not grow at 39 ˚C at all (Fig. 1A) . P tetO7 -PHS1 fen1Δ cells also exhibited a severe growth defect at 39 ˚C. These results indicate that the cells' requirement for VLCFAs is particularly significant at high temperatures.
To reveal any relationship between the chain length of the VLCFAs and the growth requirement observed above, we examined the elongase activity of the P tetO7 -PHS1 sur4Δ cells in vitro using palmitoyl-CoA as a substrate. The P tetO7 -PHS1 cells were able to elongate palmitoyl-CoA to C26-CoA, but in the P tetO7 -PHS1 sur4Δ cells elongation beyond C22-CoA was largely impaired, with no C26-CoA and only small amounts of C24-CoA produced (Fig. 1B) . These results suggest that VLCFAs with a chain length of 26 and/or 24 are required for cell growth at 39 ˚C.
Overexpression of VPS21 suppresses the temperature sensitivity of the VLCFA-limited cells
To identify genes that exhibit a close relationship with VLCFA function, we employed a multicopy suppressor screening. P tetO7 -PHS1 sur4Δ cells were transfected with a yeast genomic DNA library, and suppressors that restored growth at 39 ˚C were isolated. Of two suppressors we obtained, one comprised a plasmid containing the SUR4 gene. The other suppressor harbored a plasmid containing a genomic region encompassing the VPS21 gene, which encodes a Rab-type small GTPase involved in vesicular trafficking to the vacuole (27, 28) (Fig. S1A) . Further subcloning and growth suppression assays determined that the VPS21 gene indeed functions as a multicopy suppressor in P tetO7 -PHS1 sur4Δ cells at high temperature (Fig. S1B ). To clarify whether overexpression of Vps21 restored growth by facilitating synthesis of C24 and/or C26 VLCFA, we performed a VLCFA elongation assay. Expression of Sur4 restored the VLCFA elongation activity that produces C26-CoA and that was defective in the P tetO7 -PHS1 sur4Δ cells, but no significant difference was observed in the VLCFA elongation activity of P tetO7 -PHS1 sur4Δ cells overexpressing Vps21 and those harboring an empty vector (Fig. S1C) . Thus, Vps21 does not regulate VLCFA synthesis but may be related to the cellular functions in which VLCFAs are involved.
Deletion of the VPS21 gene causes a synthetic growth defect with deletion of the elongase genes
The growth defect in cells grown at 39 ˚C was observed not only for P tetO7 -PHS1 sur4Δ cells but also for sur4Δ cells, albeit to a lesser extent (Fig. 1A) . For simplification, we used the sur4Δ cells for further analyses.
The sur4Δ cells exhibited only slight growth retardation, both at 30 ˚C and 36 ˚C ( Fig. 2A) . Growth of the vps21Δ cells was only slightly retarded at 36 ˚C, although a significant growth defect was observed at 39 ˚C ( Fig. 2A) , as reported for 38 ˚C (28). When a vps21Δ mutation was introduced into the sur4Δ cells, the resulting sur4Δ vps21Δ cells exhibited more severe growth retardation at 30 ˚C than would be expected as an additive effect of the two single mutations ( Fig. 2A) , indicating a synthetic growth defect. Furthermore, we even observed a synthetic lethal phenotype at 36 ˚C ( Fig. 2A) . A fen1Δ vps21Δ double mutant also displayed a synthetic growth defect both at 30 ˚C and 36 ˚C ( Fig. 2A) . To address whether the synthetic effects observed were the result of alterations in VLCFA synthesis, we performed FA elongation assays. The wild-type membrane elongated C16-CoA up to C26-CoA (Fig. 2B) . However, elongations beyond C18-CoA and C22-CoA were largely impaired in fen1Δ and sur4Δ cells, respectively. These results were consistent with the previous lipidomic analysis (6), in which C16/C18 and C22 sphingolipids were increased in fen1Δ and sur4Δ cells, respectively.
Sphingolipid synthesis is known to be affected by the sur4Δ or fen1Δ mutation (6, 14 (Fig. 3A) . In vps21Δ cells, the mature CPY was also apparent, but its levels were decreased compared to those in wild type cells, and small amounts of the p2 (Golgi) form were observed intracellularly. The reduction in intracellular CPY was due to mis-sorting of the p2 CPY to the extracellular space (Fig. 3A) , as others have reported (27, 29) . In contrast, sur4Δ vps21Δ and fen1Δ vps21Δ cells accumulated significant levels of the p1 (ER) and p2 (Golgi) forms of CPY, in addition to the mature form, indicating that the CPY pathway was affected synthetically by these double mutations (Fig. 3A) . Secretion of the p2 form was also observed in both sur4Δ vps21Δ and fen1Δ vps21Δ cells, suggesting that the late secretory pathways are not impaired in these cells. Such synthetic effects were also confirmed by a pulse-chase experiment (Fig. 3B) . Nearly all newly synthesized CPY was converted to the mature form within 20 min in wild type, fen1Δ, and sur4Δ cells. In vps21Δ cells, though, the mature CPY levels were decreased compared to those in wild type cells, and significant amounts of the p2 form were detected after a 20 min chase. Introducing the fen1Δ or sur4Δ mutation into the vps21Δ cells enhanced the defect in the CPY transport. The mature CPY was nearly undetectable after a 20 min chase, and the p2 levels became more prominent in these double mutants (Fig. 3B) . Similar results were obtained for Pep4. Nearly all Pep4 was detected as the mature form in wild type, vps21Δ, fen1Δ, and sur4Δ cells, while in vps21Δ cells the Pep4 levels were decreased (Fig. 3C) . In contrast, sur4Δ vps21Δ and fen1Δ vps21Δ cells significantly accumulated the Pep4 proform. These results indicate that the deletions of VPS21 and SUR4 or FEN1 synthetically affect the CPY pathway.
We next examined the transport of the vacuolar carboxypeptidase Cps1. Cps1 is synthesized as a membrane protein in the ER, then transported to the vacuole lumen via the Golgi and the late endosome/MVB, where it is sorted into the intraluminal vesicles, then processed to its mature form. Fluorescence microscopy using mRFP-fused Cps1 (mRFP-Cps1) indicated that Cps1 was normally localized in the vacuole lumen in wild type cells (Fig. 4A) . In sur4Δ and fen1Δ cells, vacuoles were highly fragmented, as reported by others (30, (Figs. 4A and S4) . Interestingly, fragmentation of the vacuole observed in the sur4Δ and fen1Δ mutants was reduced in these double mutants (Fig. S3) .
We also confirmed the defect in Cps1 transport in sur4Δ vps21Δ and fen1Δ vps21Δ cells by immunoblot using an anti-DsRed antibody that detects mRFP. After delivery into the vacuole lumen, the linker portion of mRFP-Cps1 is cleaved by vacuolar proteases, releasing the mRFP moiety (32). The free mRFP was detected in wild type, vps21Δ, fen1Δ, and sur4Δ cells but not in sur4Δ vps21Δ or fen1Δ vps21Δ cells (Fig. 4B ),
indicating that mRFP-Cps1 was not delivered to the vacuole lumen in the sur4Δ vps21Δ or fen1Δ vps21Δ cells.
These results indicate that the transport of membrane proteins via intraluminal vesicle formation is severely impaired in sur4Δ vps21Δ and fen1Δ vps21Δ cells.
We next investigated the endocytic pathway in sur4Δ vps21Δ and fen1Δ vps21Δ cells using Ste2, a G The endocytic pathway was also not significantly affected in sur4Δ or fen1Δ cells, since Ste2-mRFP was observed in the lumen of the fragmented vacuoles (Figs. 5A and S5) . In vps21Δ cells, Ste2-mRFP was detected at the plasma membrane and as intracellular punctuates as well as the vacuole lumen, indicating that endocytosis of Ste2-mRFP is severely affected in the vps21Δ cells, consistent with reports that Vps21 is involved in endocytosis (36) . In the sur4Δ vps21Δ and fen1Δ vps21Δ double mutants, the Ste2-mRFP signal was mainly detected at the plasma membrane and in some punctate structures in the cytosol (Figs. 5A and S5).
However, it was not clear whether the endocytotic pathways in the sur4 Δ vps21Δ and fen1Δ vps21Δ double mutants were more severely affected than those in the vps21Δ cells from these fluorescence microscopic results.
Therefore, we also evaluated Ste2-mRFP endocytosis by immunoblot. In strong agreement with the results of the microscopy, the mRFP moiety released from Ste2-mRFP in the vacuole was detected in wild type, fen1Δ, and sur4Δ cells (Fig. 5B) . Free mRFP was largely reduced in vps21Δ cells but could still be detected (Fig. 5B) .
However, no free mRFP was detected in sur4Δ vps21Δ or fen1Δ vps21Δ cells (Fig. 5B) . Thus, similar to results with the Cps1 transport, synthetic effects of vps21Δ and sur4Δ or fen1Δ were observed in Ste2-mRFP endocytosis.
Some vacuolar proteins are transported to the vacuole directly from the Golgi without passing through the late endosome/MVB. This pathway is called the AP-3 pathway. The alkaline phosphatase Pho8, a type II membrane protein, is the most characterized cargo of this pathway (37, 38) . The 74 kDa Pho8 proform is processed into a 72 kDa mature form upon delivery to the vacuoles, and some protein is further processed into a 66 kDa soluble mature form (39) . In wild type cells most of the Pho8 detected was the mature form, and almost no proform was observed (Fig. 3C) . In contrast, in vps21Δ cells a fraction of the Pho8 was present as the proform, as reported by others (40) . In sur4Δ and fen1Δ cells, almost all of the Pho8 was the vacuole form, either the mature or soluble mature form (Fig. 3C) , suggesting that the AP-3 pathway was not impaired. The soluble mature form was increased in the sur4Δ and fen1Δ cells compared to wild type cells due to some unknown reason. Introduction of the vps21Δ mutation into the sur4Δ or fen1Δ cells had no effect on the maturation of Pho8 (Fig. 3C) , suggesting that the AP-3 pathway was intact in the sur4Δ vps21Δ and fen1Δ vps21Δ cells. Overall, protein transport pathways utilizing the late endosome/MVB were impaired in the sur4Δ vps21Δ and fen1Δ vps21Δ cells, but those pathways that bypass the organelle were not.
Sphingolipids containing VLCFAs function in Vps21-related vesicular transport pathways
In yeast, the vast majority of VLCFAs are incorporated into sphingolipids as part of the hydrophobic backbone formed by ceramide, which contains FA such as a VLCFA (16, 17) . Thus, it is highly likely that Growth of the ipt1Δ vps21Δ cells at 30 ˚C and 36 ˚C was comparable to that of wild type cells or those carrying either single mutation (Fig. 6A) . Likewise, the csg1Δ csh1Δ mutants grew normally, while, in contrast, the csg1Δ csh1Δ vps21Δ triple mutant displayed severe growth defects, especially at 36 ˚C (Fig. 6B) . To further analyze the synthetic effect of the csg1Δ csh1Δ and vps21Δ mutations, vesicular transport pathways in the csg1Δ csh1Δ vps21Δ cells were compared with those in the csg1Δ csh1Δ and vps21Δ cells. To avoid potential secondary effects caused by the severe growth defect of the csg1Δ csh1Δ vps21Δ mutations observed at 36 ˚C, we examined the vesicular transport at 30 ˚C. Fluorescence microscopy indicated that mRFP-Cps1 transport was impaired in csg1Δ csh1Δ vps21Δ cells so that mRFP-Cps1 rarely reached the vacuole lumen and instead accumulated at the vacuolar membrane, late endosome/MVB, and intracellular punctate structures (Figs. 6C and S4 ). In immunoblots, free mRFP was detected in the wild type and csg1Δ csh1Δ cells and also in the vps21Δ cells, albeit at a reduced level (Fig. 6D) . On the other hand, little free mRFP was observed in the csg1Δ csh1Δ vps21Δ cells (Fig. 6D) , confirming that transport of mRFP-Cps1 to the vacuole was impaired.
Furthermore, impairments were observed in CPY and Pep4 transport (Fig. 6D ) and in endocytosis of Ste2-mRFP (Figs. 6C and S5 ) in the csg1Δ csh1Δ vps21Δ cells. Similar to results in sur4Δ vps21Δ cells, delivery of Pho8 to the vacuole via the AP-3 pathway was not affected in the csg1Δ csh1Δ vps21Δ cells (Fig.   6D ). These findings suggest that sphingolipids are indeed involved in Vps21-related vesicular transport at the late endosome/MVB. Since the csg1Δ csh1Δ mutation and the sur4Δ mutation affect mannose and VLCFA moieties of sphingolipids, respectively, both moieties are important in this transport.
SUR4 genetically interacts with genes encoding subunits of the CORVET tethering complex
It is known that Vps21 physically interacts with the CORVET (class C core vacuole/endosome tethering) complex, which is involved in membrane tethering at the late endosome/MVB (41) . Thus, interactions between SUR4 and genes encoding the CORVET subunits were examined at the genetic level. The CORVET complex is composed of six subunits. Vps3 and Vps8 are specific to the CORVET complex, while four other subunits, Vps11, Vps16, Vps18, and Vps33, are shared with the HOPS (homotypic fusion and vacuole protein sorting) complex, which is involved in membrane tethering at the vacuole (Fig. 7C) (42) . The HOPS complex also contains Vps39 and Vps41 as specific subunits in place of Vps3 and Vps8. The factors that are specific to the CORVET and HOPS complexes are interchangeable, and thus mixed complexes (i-CORVET containing Vps3 and Vps41, and i-HOPS containing Vps39 and Vps8) also exist (41) . Severe synthetic growth defect at 36 ˚C was observed in cells carrying a deletion of the SUR4 gene together with a deletion of VPS3 (Fig. 7A) .
Deletion of VPS8, another gene encoding a CORVET-specific subunit, the Vps21 effector, conferred a synthetic growth defect at 36 ˚C when combined with the SUR4 deletion (Fig. 7A) , although the effect was weaker than that observed with the VPS3 deletion. This weak phenotype may be explained by the functional complementation of another Vps21 effector, Vps19 (43), since simultaneous deletion of VPS19 and VPS8 in sur4Δ cells caused a severe synthetic growth defect at nearly the same levels as found in the sur4Δ vps21Δ and sur4Δ vps3Δ mutants (Fig. 7B) . In addition, deletion of VPS41 or VPS39, which encode HOPS-specific components, caused a moderate synthetic growth defect at 36 ˚C when combined with the SUR4 deletion, implying that i-CORVET and i-HOPS formation affect the levels, function, or stability of the CORVET complex. These results further reinforce the notion that VLCFAs function in vesicular trafficking at the late endosome/MVB together with Vps21.
DISCUSSION
VLCFAs have essential physiological functions in eukaryotes, and cells carrying double deletions of the redundant yeast FA elongases FEN1 and SUR4, which are involved in VLCFA synthesis, cannot grow in any temperature (12) . However, it still remains unclear in which cellular processes VLCFAs exert their essential functions. In the presented study using yeast cells that produce limited VLCFAs, we found that the VLCFA requirement is especially high at elevated temperatures. Based on this finding, we carried out a genetic screening to identify factors that are related to VLCFA functions at the molecular level, and identified the proposed for the formation of the nuclear pore complex, around which highly curved membranes also exist (10) . Thus, it would seem likely that VLCFAs are involved in vesicular trafficking by stabilizing highly curved membranes. Similar to conditions observed for vesicle budding and fusion, intraluminal vesicle formation at the late endosome/MVB requires generation of highly curved membrane at the neck of invagination. We detected mRFP-Cps1 on the vacuole membrane in the sur4Δ vps21Δ and fen1Δ vps21Δ mutants (Fig. 4A) ,
suggesting that VLCFAs are also required for the formation of intraluminal vesicles. Such frequent generation of curved membranes at the late endosome/MVB may cause this organelle to be highly sensitive to VLCFA-limited conditions. In the presented study, we found that VLCFA requirement is significant at elevated temperature (Fig. 1A) . It is possible that curved membrane structures are destabilized at elevated temperatures due to enhanced membrane fluidity, leading to high VLCFA requirement.
In yeast, almost no free VLCFAs exist, and most VLCFAs are incorporated into sphingolipids, although small amounts are used for GPI-anchor generation. Since GPI-anchored proteins are localized in the plasma membrane and are not involved in vesicular transport at the late endosome/MVB, the functions of VLCFAs revealed here must be elicited by those VLCFAs that are components of sphingolipids. Indeed, csg1Δ csh1Δ vps21Δ triple mutant cells, which are defective in MIPC synthesis, exhibited a growth defect at a high temperature and impairment in vesicular transport pathways active at the late endosome/MVB (Fig. 6 ). This further indicates that not only the VLCFA moiety but also the polar head group of a sphingolipid is important for the Vps21-related membrane fusion event. Although the csg1Δ csh1Δ vps21Δ cells possess the simplest complex sphingolipids, IPCs, they do not have mannose-containing MIPCs or M(IP) 2 Cs. We speculate that mannose facilitates clustering of sphingolipids through hydrogen bonds and stabilizes the membrane curvature generated by VLCFAs.
It is known that vacuoles in sur4Δ and fen1Δ mutants are fragmented (30, 31), which we confirmed in this study (Figs. 4 Vacuole fragmentation is often accompanied by defects in vacuolar protein maturation and transport (44, 45) .
However, neither sur4Δ cells nor fen1Δ cells exhibited significant defects in transport of vacuolar proteins into their fragmented vacuoles (Figs. 3 and 4) . Interestingly, levels of the soluble mature form of Pho8, a highly processed form of the mature protein, were increased in sur4Δ, fen1Δ, sur4Δ vps21Δ, and fen1Δ vps21Δ cells (Fig. 3C) , although the mechanism behind this enhanced processing is not readily understood. This phenomenon was not tightly coupled with vacuole fragmentation, since the sur4Δ vps21Δ and fen1Δ vps21Δ double mutants, in which vacuole fragmentation was less prominent, also accumulated the soluble mature Pho8 at levels similar to those in the sur4Δ and fen1Δ single mutants. In addition, unlike the defects in the endosome-mediated transport pathways, this phenomenon was not enhanced synergetically by the combination of the VPS21 deletion and deletion of SUR4 or FEN1. Thus, this phenomenon was associated with the deletion of SUR4 or FEN1 but not with VPS21 deletion. Indeed, the soluble mature Pho8 was undetectable in the csg1Δ csh1Δ vps21Δ triple mutant.
In the presented study, we have revealed the function of VLCFAs in vesicular transport at the late endosome/MVB. However, considering that VLCFAs are essential for cell growth, it is highly likely that VLCFAs function in several membrane-involved processes, including other vesicular transport pathways, as reported for the secretory pathway. Indeed, we observed an accumulation of the p1 ER form of CPY in fen1Δ vps21Δ and sur4Δ vps21Δ cells, even under our mild conditions (Fig. 3A) , suggesting that vesicular transport from the ER to the Golgi is also affected. Currently, the specific process(es) in which VLCFAs are actually involved, such as vesicle budding or fusion of the vesicle with the destination membrane, still remains unclear.
Dissection of the vesicular transport pathway into its elementary processes, and an assessment of VLCFA functions in each will be needed for further understanding.
separated by SDS-PAGE, and detected by immunoblotting with an anti-Pep4, anti-Pho8, or, to demonstrate uniform protein loading, anti-Pgk1 antibody. pro, proform; m, mature form; s, soluble mature form. anti-Pgk1 antibody. Expression levels of mRFP-Cps1 were significantly low in the fen1Δ and sur4Δ mutants, compared to the other strains used, for an unknown reason. Thus, the amounts of lysates subjected to SDS-PAGE were increased for the fen1Δ and sur4Δ mutants (three and four fold for the fen1Δ and sur4Δ cells, respectively) to make the total amount of mRFP-Cps1 plus mRFP comparable to the other strains. 
